Polskie Radio covers a newer group of weight loss drugs said to outperform Ozempic. Only the headline is available, so tap through for which drugs and what data.
Recap by typeshit. Full story at www.polskieradio.pl.
The Scientist weighs whether GLP-1 drugs could lengthen life and finds the answer still unsettled. Tap through for where the research stands.
The review covers 47 peptides from meat, leather and seafood waste and cites a 12-trial meta-analysis showing a systolic drop of about 5 mmHg, credited to the authors.
Researchers think orexin drugs could expand into ADHD and fatigue the way GLP-1s grew past diabetes. Alkermes reported early ADHD results in 50 adults.
Researchers report in Amino Acids that the peptide blocks HMGA2 at the IL6 promoter in a cell model. The authors note the work is cell culture only, far from any human use.
An obesity doctor walks through how the various GLP-1 drugs differ, shared as a reposted video on X.
17:56
DOWNSIZED looks at EASD 2026 data on an amylin-based drug reaching 23% weight loss and how it might stack up against retatrutide.
Loading…